Dr. Kwon has more than 19 years experience
performing transdermal drug delivery and
diagnostics field. He in the inventor of TheraJect's
proprietary Micro-Needle Drug Delivery
technology, and holds several granted and
pending patents. Previously Dr. Kwon was a
founder of PowderChek, Inc., a spin off of
PowderJect, Inc, where he led research and
development program applying the microporation
technology to minimally invasive, continuous
glucose monitoring. He has also been a Senior
Scientist at Pharmetrix, Inc and TheraTech, Inc (a
division of Watson Pharmaceuticals now).
|Sung-Yun Kwon, Ph.D.
CEO and Founder